Abstract
Patients with cancer commonly suffer neurologic disabilities. These neurologic disorders can be either metastatic to the brain, spinal cord, leptomeninges, or peripheral nerves or nonmetastatic including infections, vascular problems, metabolic abnormalities, side effects of therapy, or paraneoplastic syndromes. Careful diagnostic evaluation of patients with cancer and neurologic symptoms often indicates effective therapy.
MeSH terms
-
Arachnoid
-
Bacterial Infections / etiology
-
Bacterial Infections / immunology
-
Brain / blood supply
-
Brain Neoplasms / diagnostic imaging
-
Brain Neoplasms / physiopathology
-
Brain Neoplasms / secondary
-
Brain Neoplasms / therapy
-
Cerebrovascular Disorders / etiology
-
Cisplatin / adverse effects
-
Disseminated Intravascular Coagulation / etiology
-
Electroencephalography
-
Endocarditis / etiology
-
Fluorouracil / adverse effects
-
Humans
-
Lung Neoplasms
-
Melanoma
-
Meningeal Neoplasms / cerebrospinal fluid
-
Meningeal Neoplasms / diagnosis
-
Meningeal Neoplasms / physiopathology
-
Meningeal Neoplasms / secondary
-
Meningeal Neoplasms / therapy
-
Methotrexate / adverse effects
-
Neoplasms / complications*
-
Nervous System Diseases / etiology*
-
Paraneoplastic Syndromes / diagnosis
-
Paraneoplastic Syndromes / etiology
-
Pia Mater
-
Prognosis
-
Spinal Cord Compression / diagnosis
-
Spinal Cord Compression / etiology
-
Spinal Cord Compression / physiopathology
-
Spinal Cord Neoplasms / complications
-
Spinal Cord Neoplasms / diagnosis
-
Spinal Cord Neoplasms / physiopathology
-
Spinal Cord Neoplasms / secondary
-
Spinal Cord Neoplasms / therapy
-
Tomography, X-Ray Computed
-
Vinca Alkaloids / adverse effects
Substances
-
Vinca Alkaloids
-
Cisplatin
-
Fluorouracil
-
Methotrexate